(Q37801388)

23 August 2017

title

Vitiligo, reactive oxygen species and T-cells (English)

1 reference

23 August 2017

main subject

reactive oxygen species

1 reference

1 reference

Steven J Glassman

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

23 August 2017

1 reference

23 August 2017

volume

120

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

99-120

1 reference

The burden of vitiligo: patient characteristics associated with quality of life.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Vitiligo: the historical curse of depigmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Epidemiology of vitiligo in the French West Indies (Isle of Martinique).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Vitiligo: clinical findings in 1436 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Segmental vitiligo: clinical findings in 208 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Current state of vitiligo therapy--evidence-based analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Vitiligo: compendium of clinico-epidemiological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Clinical practice. Vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Guideline for the diagnosis and management of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

The Evolution of Concepts of Melanin Biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Photoprotection by melanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Lymphocytes, neuropeptides, and genes involved in alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

The hair follicle melanocytes in vitiligo in relation to disease duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Review of the etiopathomechanism of vitiligo: a convergence theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Genetic polymorphisms of glutathione S-transferase and risk of vitiligo in the Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Genome-wide association study identifies three loci associated with melanoma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Vitiligo: a manifestation of apoptosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Oxygen free radicals and systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Oxygen toxicity, oxygen radicals, transition metals and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

DNA damage and oxygen radical toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

DNA damage by iron and hydrogen peroxide in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Cytochrome-P450 enzymes and autoimmunity: expansion of the relationship and introduction of free radicals as the link.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Decreased methionine sulphoxide reductase A expression renders melanocytes more sensitive to oxidative stress: a possible cause for melanocyte loss in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Oxidative damage and mitochondrial decay in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Antioxidant activity, lipid peroxidation and skin diseases. What's new.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Oxidative stress in the pathogenesis of skin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Low Catalase Levels in the Epidermis of Patients with Vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Melanocytes are not absent in lesional skin of long duration vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Presence of epidermal allantoin further supports oxidative stress in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Free radicals in cutaneous biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Increased monoamine oxidase A activity in the epidermis of patients with vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Estrogens can contribute to hydrogen peroxide generation and quinone-mediated DNA damage in peripheral blood lymphocytes from patients with vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Epidermal H(2)O(2) accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Oxidative stress in vitiligo: photo-oxidation of pterins produces H(2)O(2) and pterin-6-carboxylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Antioxidant status in the blood of patients with active vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

The role of oxidants and antioxidants in generalized vitiligo at tissue level

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

A comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Antioxidant enzymes and lipid peroxidation at the tissue level in patients with stable and active vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

On the etiology of contact/occupational vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

A reactive ortho-quinone generated by tyrosinase-catalyzed oxidation of the skin depigmenting agent monobenzone: self-coupling and thiol-conjugation reactions and possible implications for melanocyte toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Catecholamines and vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

H(2)O(2) increases de novo synthesis of (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin via GTP cyclohydrolase I and its feedback regulatory protein in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Tetrahydrobiopterin biosynthesis, regeneration and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Phenytoin as a novel anti-vitiligo weapon

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Computer simulation of native epidermal enzyme structures in the presence and absence of hydrogen peroxide (H2O2): potential and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Activation/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Calcium-activated butyrylcholinesterase in human skin protects acetylcholinesterase against suicide inhibition by neurotoxic organophosphates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

A novel mechanism in control of human pigmentation by {beta}-melanocyte-stimulating hormone and 7-tetrahydrobiopterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

The Ca2+-binding capacity of epidermal furin is disrupted by H2O2-mediated oxidation in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Signalling mechanisms of endothelin-induced mitogenesis and melanogenesis in human melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Regulation of tyrosinase by tetrahydropteridines and H2O2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Computer simulation of heterogeneous single nucleotide polymorphisms in the catalase gene indicates structural changes in the enzyme active site, NADPH-binding and tetramerization domains: a genetic predisposition for an altered catalase in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Methionine sulfoxide reductases A and B are deactivated by hydrogen peroxide (H2O2) in the epidermis of patients with vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Epidermal oxidative stress in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Increase in total blood antioxidant status and selenium levels in black patients with active vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Role of reactive oxygen species (ROS) in apoptosis induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Response of vitiligo to narrowband ultraviolet B and oral antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Evidence for an autoimmune pathogenesis of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in Vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Therapeutic implications of autoimmune vitiligo T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Lymphocyte imbalance in vitiligo patients indicated by elevated CD4+/CD8+ T-cell ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Possible transfer of vitiligo by allogeneic bone marrow transplantation: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

T and B lymphocytes in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Decreased total numbers of peripheral blood lymphocytes with elevated percentages of CD4+CD45RO+ and CD4+CD25+ of T-helper cells in non-segmental vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Epidermal Changes in Active Vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

The lichenoid tissue reaction. A new concept of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

An immunohistological study of cutaneous lymphocytes in vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Lichenoid inflammation in vitiligo--a clinical and histopathologic review of 210 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

HLA-A2 Restricted, Melanocyte-Specific CD8+ T Lymphocytes Detected in Vitiligo Patients are Related to Disease Activity and are Predominantly Directed Against MelanA/MART1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Autoimmunity as an aetiological factor in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Imbalance of regulatory T cells in human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

Hydrogen peroxide-mediated oxidative stress disrupts calcium binding on calmodulin: More evidence for oxidative stress in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

New Insights into the Pathogenesis of Vitiligo: Imbalance of Epidermal Cytokines at Sites of Lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090603

21 January 2018

Identifiers

DOI

10.1042/CS20090603

1 reference

23 August 2017

1 reference